Standard care informed by the result of a placental growth factor blood test versus standard care alone in women with reduced fetal movement at or after 36(+0) weeks’ gestation: a pilot randomised controlled trial

BACKGROUND: Biomarkers of placental function can potentially aid the diagnosis and prediction of pregnancy complications. This randomised controlled pilot trial assessed whether for women with reduced fetal movement (RFM), intervention directed by the measurement of a placental biomarker in addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong-Buisseret, Lindsay, Godolphin, Peter J., Bradshaw, Lucy, Mitchell, Eleanor, Ratcliffe, Sam, Storey, Claire, Heazell, Alexander E. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020549/
https://www.ncbi.nlm.nih.gov/pubmed/32082609
http://dx.doi.org/10.1186/s40814-020-0561-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020549/
https://www.ncbi.nlm.nih.gov/pubmed/32082609
http://dx.doi.org/10.1186/s40814-020-0561-z

Ejemplares similares